2seventy bio, Inc.
TSVT · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $262,092 | $153,862 | $246,681 | $211,353 |
| - Cash | $92,356 | $71,244 | $59,984 | $111,864 |
| + Debt | $239,763 | $243,717 | $247,446 | $251,395 |
| Enterprise Value | $409,499 | $326,335 | $434,143 | $350,884 |
| Revenue | $22,938 | $2,926 | $13,534 | $8,967 |
| % Growth | 683.9% | -78.4% | 50.9% | – |
| Gross Profit | $17,785 | -$5,917 | $7,766 | $7,621 |
| % Margin | 77.5% | -202.2% | 57.4% | 85% |
| EBITDA | -$825 | -$21,439 | -$11,780 | -$18,680 |
| % Margin | -3.6% | -732.7% | -87% | -208.3% |
| Net Income | $482 | -$19,520 | -$9,933 | $24,879 |
| % Margin | 2.1% | -667.1% | -73.4% | 277.5% |
| EPS Diluted | 0.009 | -0.37 | -0.19 | 0.45 |
| % Growth | 102.5% | -94.7% | -142.2% | – |
| Operating Cash Flow | -$10,973 | -$9,474 | -$10,505 | -$23,142 |
| Capital Expenditures | $0 | $0 | -$34 | -$61 |
| Free Cash Flow | -$10,973 | -$9,474 | -$10,539 | -$23,203 |